The three teenagers were admitted to the hospital separately in extremely critical condition, with their hearts no longer capable of sustaining life. Facing a race against time, the clinical team implanted Ventricular Assist Devices (VADs), sophisticated mechanical pumps designed to take over the function of failing hearts. These devices provided crucial support, stabilising the patients while they were placed on the highest priority waiting list for heart transplantation.
In a region where donor organs remain scarce and transplant waiting periods can often extend for months, compatible donor hearts were identified for all three patients within a period ranging from 28 to 45 days. The successful matches enabled doctors to proceed with life-saving transplant surgeries that ultimately transformed the teenagers' prospects for survival.
The first patient, a teenager suffering from severe heart dysfunction complicated by dangerous blood clots, required a BiVAD, a specialised device that supported both sides of the heart. After spending 45 days on mechanical circulatory support, the patient underwent a successful heart transplant and was discharged within weeks of the procedure.
The second teenager had been diagnosed with a condition that caused the heart to become enlarged and weakened. Supported by a mechanical heart pump for 28 days, the patient remained stable until a suitable donor heart was found, leading to a successful transplant and recovery.
The third case involved a childhood cancer survivor who had previously lost a kidney due to a tumour. After developing severe heart failure, the teenager was placed on an artificial heart pump for 30 days before receiving a successful heart transplant, completing a remarkable recovery journey against significant medical odds.
The achievement reflects a major advancement in the availability of highly specialised cardiac treatments in India. Until recently, such complex therapies were accessible only at a limited number of specialised centres around the world.
Dr. Shashiraj Subramanya H S, Head of Paediatric Cardiology at Narayana Health, said the patients had been on the very edge of survival and that the use of artificial heart pumps as a bridge to transplantation represented a landmark moment for heart failure care in the country.
Dr. Varun Shetty, Senior Consultant in Cardiac Surgery at Narayana Health, said the organisation had spent the last decade working to make advanced technologies accessible to families who previously had few treatment options. He noted that improvements in healthcare systems and a commitment to affordability have made such life-saving therapies increasingly achievable in India.
Dr. Riyan Sukumar Shetty, Director of Paediatric Intensive Care at Narayana Health, said the teenagers initially arrived with very limited chances of survival. He described the Ventricular Assist Devices as lifesaving bridges that sustained the patients until donor hearts became available, adding that seeing them return home with their families was one of the most rewarding moments for the medical team.
Founded by Dr. Devi Shetty and headquartered in Bengaluru, Narayana Health is one of India's largest healthcare providers. The organisation operates primary, secondary and super-speciality tertiary care facilities across India and the Caribbean. Its network includes Centres of Excellence across multiple medical specialties and is supported by 18,822 professionals, including 3,868 doctors and specialists. Narayana One Health and Narayana Health Insurance operate as subsidiaries of the healthcare group.
The successful treatment of these three teenagers highlights the growing capabilities of India's advanced cardiac care system and demonstrates how cutting-edge medical technology, combined with timely organ donation, can turn seemingly impossible survival stories into life-changing recoveries.
About The Author
Comment List